rct
    2000

    Lumbrokinase attenuates myocardial ischemia-reperfusion injury and improves fibrinolytic markers

    Jin L, Jin H, Zhang G, Xu G

    Published in Clinical Hemorheology and Microcirculation

    Key Findings

    Oral lumbrokinase reduced fibrinogen and plasma viscosity and improved haemorheological measures in patients with ischaemic disease.

    Conclusions

    Early evidence for blood-rheology effects.

    Limitations

    Small, surrogate endpoints, older methods.

    Supplements Studied

    Oral lumbrokinase reduced fibrinogen and plasma viscosity in patients with ischaemic disease.

    Study Details

    Year:2000
    Sample Size:60
    Duration:4 weeks
    Quality Score:4/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.